1.25
price down icon5.34%   -0.06
after-market Handel nachbörslich: 1.29 0.04 +3.20%
loading
Schlusskurs vom Vortag:
$1.31
Offen:
$1.33
24-Stunden-Volumen:
110.88K
Relative Volume:
0.68
Marktkapitalisierung:
$14.47M
Einnahmen:
$996.00K
Nettoeinkommen (Verlust:
$-6.09M
KGV:
-2.3585
EPS:
-0.53
Netto-Cashflow:
$-9.76M
1W Leistung:
+5.98%
1M Leistung:
+15.89%
6M Leistung:
+1.64%
1J Leistung:
-20.77%
1-Tages-Spanne:
Value
$1.20
$1.3399
1-Wochen-Bereich:
Value
$1.15
$1.37
52-Wochen-Spanne:
Value
$0.70
$2.44

Therapeuticsmd Inc Stock (TXMD) Company Profile

Name
Firmenname
Therapeuticsmd Inc
Name
Telefon
561-961-1900
Name
Adresse
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Name
Mitarbeiter
1
Name
Twitter
@TherapeuticsMD
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
TXMD's Discussions on Twitter

Vergleichen Sie TXMD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
TXMD
Therapeuticsmd Inc
1.25 15.16M 996.00K -6.09M -9.76M -0.53
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
145.43 65.38B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.11 44.75B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.10 40.97B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
19.79 22.50B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
415.34 19.04B 3.08B 1.24B 1.07B 25.61

Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2020-08-07 Herabstufung Jefferies Hold → Underperform
2020-05-19 Herabstufung JP Morgan Overweight → Neutral
2019-12-02 Eingeleitet Guggenheim Buy
2019-10-17 Eingeleitet H.C. Wainwright Buy
2019-04-30 Fortgesetzt Noble Capital Markets Outperform
2018-06-15 Eingeleitet JP Morgan Overweight
2017-09-08 Eingeleitet Morgan Stanley Equal-Weight
2017-07-11 Hochstufung Oppenheimer Perform → Outperform
2017-05-09 Herabstufung Oppenheimer Outperform → Perform
2016-11-22 Fortgesetzt Jefferies Buy
2016-11-22 Eingeleitet Oppenheimer Outperform
2016-11-07 Fortgesetzt Guggenheim Buy
2016-04-04 Eingeleitet Goldman Buy
2015-12-08 Bestätigt Jefferies Buy
2015-12-08 Bestätigt Stifel Buy
2015-09-21 Bestätigt Jefferies Buy
2015-06-09 Eingeleitet Guggenheim Buy
2014-07-08 Eingeleitet FBR Capital Outperform
2014-04-17 Bestätigt Noble Financial Buy
2014-01-28 Bestätigt Noble Financial Buy
Alle ansehen

Therapeuticsmd Inc Aktie (TXMD) Neueste Nachrichten

pulisher
04:39 AM

How TherapeuticsMD Inc. (29TA) stock correlates with oil marketsSwing Trade & Accurate Intraday Trading Signals - newser.com

04:39 AM
pulisher
04:20 AM

Why TherapeuticsMD Inc. stock remains a top recommendationQuarterly Earnings Report & Technical Entry and Exit Alerts - newser.com

04:20 AM
pulisher
04:02 AM

Can TherapeuticsMD Inc. stock surprise with earnings upside2025 Growth vs Value & AI Enhanced Trading Signals - newser.com

04:02 AM
pulisher
04:01 AM

What MACD and RSI say about TherapeuticsMD Inc.2025 Performance Recap & AI Powered Buy/Sell Recommendations - newser.com

04:01 AM
pulisher
03:28 AM

Can a trend reversal in TherapeuticsMD Inc. lead to recoveryInflation Watch & Real-Time Buy Signal Alerts - newser.com

03:28 AM
pulisher
03:28 AM

Why TherapeuticsMD Inc. stock is seen as undervalued2025 Analyst Calls & Reliable Volume Spike Alerts - newser.com

03:28 AM
pulisher
01:56 AM

Key metrics from TherapeuticsMD Inc.’s quarterly dataJuly 2025 WrapUp & Verified Chart Pattern Trade Signals - newser.com

01:56 AM
pulisher
01:34 AM

Will TherapeuticsMD Inc. stock benefit from upcoming earnings reportsMarket Trend Summary & Risk Managed Investment Signals - newser.com

01:34 AM
pulisher
Oct 27, 2025

How to build a dashboard for TherapeuticsMD Inc. stockWeekly Earnings Recap & Weekly Top Gainers Trade List - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Why ETFs are accumulating TherapeuticsMD Inc. (29TA) stockDay Trade & AI Enhanced Execution Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

How to read the order book for TherapeuticsMD Inc.Earnings Miss & Real-Time Volume Triggers - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Why Jiayin Group Inc. Depositary Receipt stock attracts strong analyst attention - newser.com

Oct 27, 2025

Finanzdaten der Therapeuticsmd Inc-Aktie (TXMD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Therapeuticsmd Inc-Aktie (TXMD) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Walker Marlan D
Chief Executive Officer
Apr 14 '25
Buy
1.00
490
489
73,639
Walker Marlan D
Chief Executive Officer
Apr 10 '25
Buy
0.86
1,167
1,000
73,149
Walker Marlan D
Chief Executive Officer
Apr 09 '25
Buy
0.87
1,136
994
71,982
Collins Cooper C.
Director
Feb 18 '25
Option Exercise
0.00
8,500
0
60,516
Naughton Gail K
Director
Feb 18 '25
Option Exercise
0.00
8,500
0
8,500
Thompson Tommy G
Director
Feb 18 '25
Option Exercise
0.00
8,500
0
14,454
Walker Marlan D
Chief Executive Officer
Feb 18 '25
Option Exercise
0.00
8,281
0
70,846
$47.16
price down icon 1.87%
$22.10
price down icon 0.70%
$10.28
price down icon 1.34%
drug_manufacturers_specialty_generic RDY
$14.59
price up icon 0.79%
$147.38
price down icon 1.01%
$415.34
price down icon 1.60%
Kapitalisierung:     |  Volumen (24h):